3550 results for «225»

Filter By

3550 results

Minimalist approach to tricuspid valve therapy

11 Sep 2025 – From PCR Rio Valves 2025

This session highlights the minimalist approach to tricuspid valve therapy with TricValve implantation, a contrast-free, minimally invasive procedure guided by transthoracic echo and minimal fluoroscopy. Clinical evidence shows reduced hospitalisations, improved quality of life, and encouraging mid-term outcomes, including smaller right heart chamber dimensions and reduced...

Minimalist approach to tricuspid valve therapy

Transcatheter tricuspid valve replacement - Where are we in Latin America?

12 Sep 2025 – From PCR Rio Valves 2025

Stay abreast of the latest advances in transcatheter tricuspid valve replacement (TTVR) across Latin America. This session highlights orthotopic implant technologies, patient selection criteria, early clinical outcomes, and discusses future perspectives including training, technology access, and regional clinical impact.

Transcatheter tricuspid valve replacement - Where are we in Latin America?

Coronary artery rupture in hybrid treatment

12 Apr 2024

Find out more about the step-by-step approach to effectively manage coronary artery rupture using prolonged balloon inflation.

Paul Gamboa

Author

Paul Gamboa
Coronary artery rupture in hybrid treatment

RIPCORD 2: does routine pressure wire assessment influence management strategy of coronary angiography for diagnosis of chest pain?

29 Aug 2021

Nicola Ryan presents a synthesis of this study which compares FFR-guided assessment of patients with chest pain with angiographic guidance alone, and which was presented by Nicholas Curzen (Southampton, USA) during the ESC Congress 2021.

Nicola Ryan

Author

Nicola Ryan
RIPCORD 2: does routine pressure wire assessment influence management strategy of coronary angiography for diagnosis of chest pain?

PCR Tricuspid Focus Group

21 Apr 2021

Discover an overview of the new initiative’s mission and five ongoing working groups

Introducing the PCR Tricuspid Focus Group

MATTERHORN - Transcatheter versus surgical mitral valve repair in patients with heart failure and secondary mitral regurgitation

01 Sep 2024

Yohei Ohno provides his takeaways from the results of the MATTERHORN trial presented by Volker Rudolph at the ESC Congress 2024 in London.

Yohei Ohno

Author

Yohei Ohno
MATTERHORN

Percutaneous or surgical management of post-infarction ventricular septal defects: The United Kingdom National Registry

17 Sep 2022

Elad Asher provides his take on the UK National Registry which was presented at the TCT congress 2022 by Joel Peter Giblett on behalf of the UK PIVSD investigators.

Elad Asher

Author

Elad Asher
Percutaneous or Surgical Management of Post-Infarction Ventricular Septal Defects: The United Kingdom National Registry

BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

07 Nov 2022

Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.

This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

Nicola Ryan

Author

Nicola Ryan
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

OPTIMIZE IDE: A randomized trial of a novel, ultra low profile fixed-wire DES

26 Oct 2020

At TCT Connect 2020, Late-Breaking Trial Session IV, the primary results of the OPTIMIZE IDE were presented by Dean J. Kereiakes. Daniele Giacoppo provides a summary of the trial.

Daniele Giacoppo

Author

Daniele Giacoppo
Live from TCT Connect 2020: The OPTIMIZE trial

ISAR REACT 5 - Ticagrelor versus prasugrel in patients with acute coronary syndrome

03 Sep 2019

At the ESC Congress 2019 in Paris, Stefanie Schuepke presented the results of the ISAR REACT 5 study. Read this analysis by Francesco Costa and view a short interview with Stefanie Schuepke.

Francesco Costa

Author

Francesco Costa
ISAR REACT 5 - Ticagrelor vs prasugrel in patients with acute coronary syndrome
Didn’t find what you were looking for?